Butterworth-Heinemann, 1994
It can increase the bioavailability of certain medications like Levodopa, enhancing their therapeutic effects and potential side effects
Sanz-Moreno, V., Gadea, G., Ahn, J., Paterson, H., Marra, P., Pinner, S., et al
In: De Simone R, Martelli EA (eds) Stress, Immunity and AgeingA Role for Acetyl L carnitine Excerpta Medica: Amsterdam 1989
In sum, much current research is aimed at understanding the endogenous GLP-1 system in the brain, particularly how GLP-1R agonists gain access to certain regions of the brain and their effects once they are in the brain, but the complexity of GLP-1 pathways has so far kept scientists from developing a complete understanding of the system.
A low result is obviously a big red flag, but it's crucial to know that this test alone doesn't always tell the whole story